Page 93 - IngresoDr.MtzLanao

Trenfield SJ, Awad A, Madla CM, Hatton GB, Firth J, Goyanes A, Gaisford S, Basit AW (2019).
Shaping the future: recent advances of 3D printing in drug delivery and healthcare. Expert Opin
Drug Deliv., 16(10): 1081-1094.

Truong V. Kumar SR, Pang JS, Liu YK, Chen DW, Lue SJ (2020). Synergistic Antibacterial Activity
of Silver-Loaded Graphene Oxide towards Staphylococcus Aureus and Escherichia Coli.
Nanomaterials (Basel)., 10, doi:10.3390/nano10020366.

Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL (2014). The Biopharmaceutics
Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Eur J Pharm Sci., 57: 152-163.

USP Subcommittee on Biopharmaceutics. In vitro/in vivo correlation for extended release oral
dosage forms. Pharm. Forum 14(4): 4160-4161. 1988.

Utembe W, Clewell H, Sanabria N, Doganis P, Gulumian M (2020). Current Approaches and
Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.
Nanomaterials (Basel)., 10(7): 1267.

Van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T (2019). Smart cancer
nanomedicine. Nat Nanotechnol. 14(11): 1007-1017.

Vass P, Démuth B, Hirsch E, Nagy B, Andersen SK, Vigh T, Verreck G, Csontos I, Nagy ZK, Marosi
G (2019). Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals. J
Control Release., 296: 162-178.

Vaz VM, Kumar L (2021). 3D Printing as a Promising Tool in Personalized Medicine. AAPS
PharmSciTech., 22(1): 49.

Vijayavenkataraman S, Fuh JYH, Lu WF (2017). 3D Printing and 3D Bioprinting in Pediatrics
Bioengineering., 4: 63.

Vijayavenkataraman S, Yan WC, Lu WF, Wang CH, Fuh JYH (2018). 3D bioprinting of tissues and
organs for regenerative medicine. Adv Drug Deliv Rev., 132: 296-332.

Vinci C, Brandon KO, Kleinjan M, Brandon TH (2020). The clinical potential of augmented reality.
Clin Psychol (New York)., 27(3): e12357.

Wagner JG (1961). Biopharmaceutics: absorption aspects. J Pharm Sci., 50: 359-387.

Wagner JG (1960). A nose on the correlation of in vivo with in vitro disintegration times of
enteric-coated tablets J Am Pharm Assoc Sci Ed., 49: 179.

Wagner JG, Nelson E (1963). Percent absorbed time plots derived from blood level and/or
urinary excretion data. J. Pharm. Sci., 52: 610-611.

Wagner JG, Gerard ES, Kaiser DG (1966). The effect of the dosage form on serum levels of
indoxole. Clin Pharmacol Ther., 7: 610-619.

Wagner JG: Metzler C (1969). Prediction of blood levels after multiple doses from single dose
blood level data: data generated with two-comparment open model analyzed according to the
one-compartment open model. J Pharm Sci., 58: 87-92.

91